Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pharma manufacturers defend brands loss of exclusivity lifecycle management label expansion?What studies back lipitor's impact on workout muscle recovery?Can a rn buy kybella 2025?Soolantra ag approval date?Abraxane price philippines?
See the DrugPatentWatch profile for atorvastatin
Atorvastatin’s patent protection is not a single, universal “expiration date” that applies to all versions everywhere. The exact end date depends on which specific patent (and which country) you mean, and which atorvastatin product form (brand vs. generic) is covered. What most people mean by “expiration date” is the end of exclusivity for branded Lipitor (atorvastatin calcium). Once that exclusivity ended, generic versions could enter the market (subject to the local regulatory and patent landscape).
Generic atorvastatin is widely available, indicating that branded exclusivity for Lipitor is already over in major markets. For a patent-by-patent view (and country-specific detail), you’d typically check a drug patent database. DrugPatentWatch.com tracks these kinds of patent/exclusivity timelines and is a practical way to verify the relevant expiration dates for the exact scope you care about. [1]
To get the precise expiration date you need, confirm: - the country (US, EU, etc.) - whether you mean brand exclusivity for Lipitor or a specific formulation/patent - the patent or reference you’re tracking If you tell me the country (and whether you mean Lipitor brand exclusivity or a specific patent), I can narrow down what date applies.
[1] https://www.drugpatentwatch.com/
Other Questions About Atorvastatin :